ScholarGate
Asistente

Comparar métodos

Revisa los métodos seleccionados uno junto a otro; las filas que difieren aparecen resaltadas.

Ensayo Clínico Aleatorizado de Fase III con Emparejamiento×Emparejamiento por Puntuación de Propensión×
CampoEpidemiologíaEstadística para la investigación
FamiliaProcess / pipelineProcess / pipeline
Año de origenMid-20th century (matching in RCTs formalized ~1950s–1970s)1983
Autor originalFisher, R. A. (matching principles); adapted into confirmatory trial design over mid-20th centuryPaul Rosenbaum and Donald Rubin
TipoControlled confirmatory clinical trial with matchingMethod
Fuente seminalRothman, K. J., Greenland, S., & Lash, T. L. (2008). Modern Epidemiology (3rd ed.). Lippincott Williams & Wilkins. ISBN: 978-0781755641Rosenbaum, P. R., & Rubin, D. B. (1983). The central role of the propensity score in observational studies for causal effects. Biometrika, 70(1), 41–55. DOI ↗
Aliasmatched controlled Phase III trial, Phase III matched-pair trial, matched confirmatory trial, matched late-phase RCTPSM, propensity score weighting, covariate balance
Relacionados53
ResumenA matched Phase III clinical trial is a confirmatory, late-stage controlled study in which each participant assigned to the experimental treatment is paired with one or more controls who share key prognostic characteristics — such as age, disease stage, or comorbidities — before treatment allocation. By ensuring baseline comparability at the level of matched pairs, the design reduces confounding and improves statistical efficiency in settings where simple randomization alone may produce imbalanced groups or where full randomization is logistically or ethically constrained.Propensity score matching (PSM) is a method for reducing confounding bias in observational studies by balancing baseline characteristics between treatment groups, simulating randomization. Developed by Rosenbaum and Rubin (1983), it estimates the probability of receiving treatment given observed covariates, then matches or weights treated and control individuals with similar treatment probabilities. Widely used in medicine, epidemiology, and policy evaluation when randomized trials are infeasible or unethical, enabling estimation of treatment effects while controlling for selection bias.
ScholarGateConjunto de datos
  1. v1
  2. 2 Fuentes
  3. PUBLISHED
  1. v1
  2. 3 Fuentes
  3. PUBLISHED

Ir a la búsqueda Descargar diapositivas

ScholarGateComparar métodos: Matched Phase III Clinical Trial · Propensity Score Matching. Recuperado el 2026-06-19 de https://scholargate.app/es/compare